Centessa Pharmaceuticals plc - stock earnings
CNTA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -38.6 million USD | ? USD |
| 2023Q2 | -24.9 million USD | ? USD |
| 2023Q1 | -50.7 million USD | ? USD |
| 2022Q4 | -43.2 million USD | ? USD |
| 2022Q3 | -53.9 million USD | ? USD |
| 2022Q2 | -64.7 million USD | ? USD |
| 2022Q1 | -54.5 million USD | ? USD |
| 2021Q4 | -60.8 million USD | ? USD |
| 2021Q3 | -40.2 million USD | ? USD |
| 2021Q2 | -41.5 million USD | ? USD |
| 2021Q1 | -239.5 million USD | ? USD |
| 2020Q4 | -10.7 million USD | ? USD |
| 2020Q2 | -2.2 million USD | ? USD |
| 2020Q1 | -3.0 million USD | ? USD |
CNTA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -157.4 million USD | ? USD |
| 2022 | -216.2 million USD | ? USD |
| 2021 | -381.9 million USD | ? USD |
| 2020 | -11.0 million USD | ? USD |
| 2019 | -5.3 million USD | ? USD |
CNTA
Price: $9.17
52 week price:
Earnings Per Share: -1.57 USD
P/E Ratio: -6.56
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 66900
Market Capitalization: 1.1 billion